nephropathy is any disease, damage, or functional abnormality of the kidneys. It is distinguished from nephritis (inflammation of the kidney, often immune‑mediated) and nephrosis (degenerative change without significant inflammation, typically with heavy proteinuria). The underlying mechanisms include chronic hyperglycemia (diabetic nephropathy), systemic hypertension (hypertensive nephropathy), immune complex deposition (IgA nephropathy, membranous nephropathy), toxins, drugs, or reflux of urine. Nephropathy is always pathological; there is no physiological form. Clinically relevant subtypes encountered in coding include diabetic nephropathy (ICD‑10‑CM E11.21 for type 2, E10.21 for type 1), hypertensive nephropathy (I12.9), IgA nephropathy (N02.8), membranous nephropathy (N03.2), and reflux nephropathy (N13.72). Unlike chronic kidney disease (CKD) - which is a functional staging of any cause - nephropathy specifies an underlying disease process; however, the two are often coded together when a CKD stage is documented (e.g., N18.32 for stage 3b).
The word entered English in the 1830s as nephropathy (noun), borrowed directly from Neo‑Latin nephropathia, from Greek nephrós (“kidney”) + páthos (“disease”). The root nephr‑ (“kidney”) connects nephropathy to the entire -nephr FAMILY: nephrectomy (kidney removal), nephrolithiasis (kidney stones), nephrosis (degenerative kidney disease), and nephron (functional unit of the kidney). The suffix -pathy appears widely in medical terminology: cardiomyopathy, neuropathy, myopathy, retinopathy.
🔀 ALIASES / ALTERNATE TERMS
Nephropathic (adjective form — “nephropathic cystinosis,” “nephropathic amyloidosis,” “nephropathic hypertension”)
Kidneydisease (lay term; used interchangeably in patient communication)
Renal disease (clinical synonym; preferred in many specialties)
Kidneydamage (general descriptor; often used before significant functional decline)
Diabetic kidney disease|Diabetic nephropathy (etiologic subtype; code E11.21 for type 2, E10.21 for type 1; typically includes albuminuria >300 mg/day)
Hypertensivenephropathy (etiologic subtype; due to chronic hypertension; code I12.9; often with CKD stage, e.g., I12.0 with CKD stage 1‑4)
IgAnephropathy (immune complex subtype; mesangial deposition of IgA; code N02.8; most common glomerulonephritis worldwide)
Membranous nephropathy (autoimmune subtype; thickening of glomerular basement membrane; code N03.2; often associated with PLA2R antibodies)
Reflux nephropathy (anatomic subtype; due to vesicoureteral reflux causing scarring; code N13.72)
Toxic nephropathy (etiologic subtype; caused by drugs, contrast media, heavy metals; code N14.1 for NSAID‑induced, N14.2 for other drug‑induced, N14.3 for heavy metal)
Analgesic nephropathy]] (toxic subtype from chronic analgesic use; code N14.1)
HIV‑associated nephropathy (collapsing focal segmental glomerulosclerosis in HIV; code N08 with underlying B20)
🔗 RELATED TERMS
Nephritis — inflammation of the kidney (often immune‑mediated, presenting with hematuria, RBC casts, hypertension). Distinguish from nephropathy, which is a broader term covering non‑inflammatory damage.
nephrosis — same‑root sibling term; degenerative kidney disease with minimal inflammation, classically presenting with nephrotic syndrome (heavy proteinuria, edema). Nephropathy may include nephrosis as a subtype (e.g., membranous nephropathy).
Chronic kidney disease (CKD) — closely related clinical entity; functional staging of kidney damage (N18.1‑N18.6) that often accompanies nephropathy. Code nephropathy first as etiology, then CKD stage.
Acute kidney injury (AKI) — rapid decline in kidney function, sometimes due to acute nephropathy (e.g., toxic nephropathy from contrast); code with N17.9 or specific cause.
Proteinuria — mechanism term; abnormal protein in urine (R80.9), a hallmark of glomerular nephropathies; persistent proteinuria >300 mg/day defines diabetic nephropathy.
Albuminuria — more specific measure; ACR (albumin‑to‑creatinine ratio) used to stage diabetic kidney disease.
glomerulosclerosis — cellular mechanism term; scarring of glomeruli, final common pathway of many nephropathies (diabetic, hypertensive, IgA).
diabetic nephropathy — disease entity using this term; microvascular complication of diabetes; code E11.21 (type 2) or E10.21 (type 1). Leading cause of ESRD.
Hypertensive nephropathy — disease entity; also called hypertensive renal disease; code I12.9. Overlaps with benign nephrosclerosis.
Polycystic kidney disease — genetic disease often called cystic nephropathy; code Q61.2 (autosomal dominant) or Q61.3 (autosomal recessive).
Lupus nephritis — immune complex nephropathy in SLE; code M32.14 (lupus nephritis) - note this is nephritis, but often referred to as lupus nephropathy.
Renal biopsy — primary diagnostic procedure for nephropathy (except diabetic/hypertensive, which are clinical diagnoses); CPT 50200 (percutaneous needle biopsy).
CODING CORNER
🏥 ICD-10-CM CODES
Diabetic Nephropathy (E08‑E13 with .21) - Diabetes Type Must Be Specified
Code
Description
E10.21
Type 1 diabetes mellitus with diabetic nephropathy
E11.21
Type 2 diabetes mellitus with diabetic nephropathy
E08.21
Drug/chemical induced diabetes mellitus with diabetic nephropathy
E09.21
Secondary diabetes mellitus with diabetic nephropathy
E13.21
Other specified diabetes mellitus with diabetic nephropathy
Hypertensive Nephropathy (I12.-) - Code with CKD Stage When Documented
Code
Description
I12.9
Hypertensive chronic kidney disease without stage (use only if CKD stage not documented)
I12.0
Hypertensive chronic kidney disease with stage 1 through 4 or unspecified CKD (code additional N18.1‑N18.4, N18.9)
Creatinine, blood (basic assessment of kidney function)
82040
Albumin, serum (to assess nutritional status and protein loss)
82043
Albumin, urine, quantitative (e.g., immunoturbidimetric) - core test for diabetic nephropathy
82044
Albumin, urine, by dipstick (semi‑quantitative) - used for screening
84156
Protein, urine, quantitative (24‑hour or random with creatinine ratio)
81001
Urinalysis, automated with microscopy (detects RBC casts, dysmorphic RBCs indicative of glomerular injury)
90935
Hemodialysis procedure, single treatment (for ESRD due to nephropathy)
90945
Peritoneal dialysis procedure, single treatment
90960
End‑stage renal disease (ESRD) service, 1 month, for patient 20+ years, with 4 or more face‑to‑face visits
⚠️ Coding Note: For inpatient profee coding, nephropathy codes usually do not require laterality except for reflux nephropathy (N13.72 unilateral vs N13.73 bilateral). The correct sequencing: code the underlying etiology first (e.g., diabetes E11.21, hypertensionI12.9), then the nephropathy code if it is an inherent descriptor (as in diabetic nephropathy, the .21 code already includes “with diabetic nephropathy” - do not add a separate nephropathy code). For hypertensive nephropathy, code I12.9 or I12.0 as principal, then add the appropriate CKD stage from N18.1‑N18.6. An undercoding alert: unspecified N28.9 (disorder of kidney) is frequently used when the documentation says “nephropathy” without specifying type - this is a missed opportunity. If the physician documents “IgA nephropathy” or “membranous nephropathy,” specific codes N02.8 or N03.2 must be used. Documentation trigger phrases like “chronic kidney disease presumed due to hypertension” or “proteinuria with diabetic history” should prompt a query for specificity. Payer considerations: For diabetic nephropathy, medical necessity for ACE inhibitor or ARB therapy often requires code E11.21 plus a CKD stage. Prior authorization for renal biopsy (CPT 50200) requires documented suspicion of a primary glomerular disease (e.g., nephrotic syndrome) and exclusion of diabetic/hypertensive causes. Type/subtype specificity: For IgA nephropathy, code N02.8 requires that the diagnosis was confirmed by biopsy; if biopsy not performed, use N02.9 (unspecified morphologic changes). Similarly, minimal change disease requires N04.2 (nephrotic syndrome with lesion) - do not use N05.2 (without syndrome).